文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Cured but breathless: the growing burden of DIILD in cancer survivors.

作者信息

Li Jing-Xing, Cheng Wen-Chien

机构信息

Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.

出版信息

Nat Rev Clin Oncol. 2025 Aug 13. doi: 10.1038/s41571-025-01064-4.

DOI:10.1038/s41571-025-01064-4
PMID:40804487
Abstract
摘要

相似文献

[1]
Cured but breathless: the growing burden of DIILD in cancer survivors.

Nat Rev Clin Oncol. 2025-8-13

[2]
Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab-sarotalocan sodium in a patient with oropharyngeal cancer: A case report.

Respir Med Case Rep. 2025-7-5

[3]
Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs.

Expert Opin Drug Saf. 2025-8

[4]
Mobile Apps and Quality of Life in Patients With Breast Cancer and Survivors: Systematic Literature Review.

J Med Internet Res. 2023-7-26

[5]
Parents' perceptions and experiences of physical activity in childhood cancer survivors in Singapore: a qualitative study.

Singapore Med J. 2025-6-1

[6]
Direct Economic Burden of Post-Cancer Treatment Pain Among Cancer Survivors in the United States: A Population-Based Retrospective Longitudinal Study.

Int J Health Plann Manage. 2025-7

[7]
Accelerometer measurement error in a randomized physical activity intervention trial in breast cancer survivors was nondifferential but attenuated the intervention effect.

Int J Behav Nutr Phys Act. 2025-5-26

[8]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[9]
Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

J Clin Oncol. 2025-8-11

[10]
Diabetes in childhood cancer survivors: emerging concepts in pathophysiology and future directions.

Front Med (Lausanne). 2023-8-22

本文引用的文献

[1]
F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors.

Acad Radiol. 2025-2

[2]
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective.

Curr Oncol. 2023-8-30

[3]
Optimizing the safety of antibody-drug conjugates for patients with solid tumours.

Nat Rev Clin Oncol. 2023-8

[4]
Trastuzumab Deruxtecan in -Mutant Non-Small-Cell Lung Cancer.

N Engl J Med. 2022-1-20

[5]
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.

JAMA Oncol. 2020-6-1

[6]
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

N Engl J Med. 2019-12-11

[7]
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.

J Thorac Oncol. 2018-11-30

[8]
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.

JAMA Oncol. 2018-12-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索